# Olivier Casasnovas

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/olivier-casasnovas/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,164 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 86 |
| i10-index | 256 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5062305482 |
| ORCID iD | https://orcid.org/0000-0002-1156-8983 |
| Works | 627 |

## Researcher papers

- [Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma](https://scholariq.org/papers/rituximab-plus-lenalidomide-in-advanced-untreated-follicular-lymphoma/)
- [Safety and activity of the anti-CD79B antibody–drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study](https://scholariq.org/papers/safety-and-activity-of-the-anti-cd79b-antibody-drug-conjugate-polatuzumab/)
- [Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network](https://scholariq.org/papers/primary-cns-lymphoma-at-first-relapse-progression-characteristics-management-and/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.